QPGx‐CARES: Qatar pharmacogenetics clinical applications and research enhancement strategies
<p dir="ltr">Pharmacogenetic (PGx)‐informed medication prescription is a cutting‐edge genomic application in contemporary medicine, offering the potential to overcome the conventional “trial‐and‐error” approach in drug prescription. The ability to use an individual's genetic pro...
محفوظ في:
| المؤلف الرئيسي: | Rania Abdel‐latif (14778559) (author) |
|---|---|
| مؤلفون آخرون: | Radja Badji (14152548) (author), Shaban Mohammed (14150130) (author), Wadha Al‐Muftah (14778553) (author), Hamdi Mbarek (134997) (author), Dima Darwish (14152545) (author), Duha Assaf (21841469) (author), Daoud Al‐Badriyeh (21841472) (author), Hazem Elewa (3592601) (author), Nahla Afifi (193245) (author), Naseer Ahmad Masoodi (21841475) (author), Amr Salah Omar (17151028) (author), Jassim Al Suwaidi (21841478) (author), Salha Bujassoum (18186793) (author), Moza Al Hail (21841481) (author), Said I. Ismail (11721428) (author), Asma Althani (193235) (author) |
| منشور في: |
2024
|
| الموضوعات: | |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة
-
Implementing CYP2C19 Pharmacogenetic Testing for Personalized Antiplatelet Therapy: Findings From the QPGx-CARES Initiative
حسب: Rania Abdel-latif (18295396)
منشور في: (2025) -
Forging the path to precision medicine in Qatar: a public health perspective on pharmacogenomics initiatives
حسب: Kholoud Bastaki (18434094)
منشور في: (2024) -
Willingness to participate in genome testing: a survey of public attitudes from Qatar
حسب: Hanan F. Abdul Rahim (9330201)
منشور في: (2020) -
Effect of SAMe-TT<sub>2</sub>R<sub>2</sub> score and genetic polymorphism on the quality of anticoagulation control in Qatari patients treated with warfarin
حسب: Hazem Elewa (3592601)
منشور في: (2020) -
Analysis of 14,392 whole genomes reveals 3.5% of Qataris carry medically actionable variants
حسب: Amal Elfatih (14778550)
منشور في: (2024)